Cohorts of Docetaxel or Cabazitaxel in Combination With the Potent CYP3A4 Inhibitor, Clarithromycin
Clinical trial NCT03043989 · TERMINATED
Trial details
- NCT number
- NCT03043989
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-21
- Primary completion
- 2019-07-26
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.